BioMarin Pharmaceutical
BMRN
#1438
Rank
C$16.60 B
Marketcap
$86.58
Share price
2.02%
Change (1 day)
-29.38%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2024 (TTM): C$0.74 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are C$2.85 Billion. , an increase over its 2023 earnings that were of C$0.26 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2024

Annual earnings

Year Earnings Change
2024 C$0.74 B187.31%
2023 C$0.26 B26.07%
2022 C$0.20 B-298.51%
2021 -C$0.11 Billion78.04%
2020 -C$58.41 Million-55.36%
2019 -C$0.14 Billion-33.56%
2018 -C$0.2 Billion297.78%
2017 -C$49.51 Million-95.68%
2016 -C$1.15 Billion437.12%
2015 -C$0.22 Billion23.91%
2014 -C$0.18 Billion-29.25%
2013 -C$0.25 Billion49.23%
2012 -C$0.17 Billion171.11%
2011 -C$60.21 Million103.01%
2010 -C$29.66 Million-3903.54%
2009 C$0.77 M-98.31%
2008 C$46.12 M-189.7%
2007 -C$51.43 Million51.02%
2006 -C$34.06 Million-61.58%
2005 -C$88.62 Million-56.59%
2004 -C$0.21 Billion95.13%
2003 -C$0.11 Billion12.09%
2002 -C$93.33 Million73.19%
2001 -C$53.89 Million18.32%
2000 -C$45.55 Million19.65%
1999 -C$38.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.7 Billion-193.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.14 Billion-118.17%๐Ÿ‡บ๐Ÿ‡ธ USA
C$10.35 M-98.61%๐Ÿ‡บ๐Ÿ‡ธ USA
C$10.96 B 1,365.96%๐Ÿ‡ซ๐Ÿ‡ท France
-C$39.69 Million-105.31%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.29 B-60.08%๐Ÿ‡บ๐Ÿ‡ธ USA